NCT05342298 (OCID) is a clinical trial of prediction model in Ovarian Cyst, sponsored by Assiut University.

Who is sponsoring NCT05342298?

NCT05342298 is sponsored by Assiut University.

What drugs are being tested in NCT05342298?

Interventions in NCT05342298: prediction model.

What condition does NCT05342298 study?

NCT05342298 studies Ovarian Cyst.

Is NCT05342298 still recruiting?

NCT05342298 is currently status unknown. Last updated 23 August 2022.

Last reviewed 2022-08-23 · How we verify

NCT05342298: OCID

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Ovarian Cysts Using Machine Learning

Status unknown Last updated 23 August 2022

What this trial tests

trial testing prediction model in Ovarian Cyst in 1,000 participants. Status unknown.

Timeline

1 October 2022

Primary endpoint
1 June 2023

1 September 2023

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	1 October 2022
Primary completion	1 June 2023
Estimated completion	1 September 2023
Sites	2 locations across Egypt

Drugs / interventions tested

prediction model

Conditions studied

Ovarian Cyst — all drugs for Ovarian Cyst →

Sponsor

Assiut University

Who can join

Adults 15 to 80, female only, with Ovarian Cyst. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims at creating a prediction model using machine learning algorithms that is capable of predicting malignant potential of ovarian cysts/masses based on patient characteristics, sonographic findings, and biochemical markers

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05342298 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 23 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05342298.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing